Hussam Hamdalla, MD
Interventional Cardiology · Lexington, KYNPI 1871527804
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 56 manufacturers reported payments, led by Shockwave Medical, Inc at 43.3% of the total. 2025 is the largest year on record at $7,582, 2.1 times the $3,657 reported in 2019.
Across 450 payments — averaging $53.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$11K
- Medtronic$3K
- Terumo Medical Corporation$2K
- Novartis$974
- Boston Scientific$862
- Endologix LLC$757
- plus $6K from 50 others
Across 4 payments — averaging $4261.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$17K
What the payments were for
- Consulting fees$5,50023%
- Speaking & faculty fees$4,95020%
- Travel & lodging$2,46910%
- Food & beverage$11,35047%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$10,450
- Navicross$1,488
- AZUR$1,488
- GlideWire$1,488
- ONYX FRONTIER$1,352
- PANTHERIS$425
- AFX$258
- ARTIX MT$168
- Supera peripheral stent system$165
- Ovation$150
- Alto Abdominal Stent Graft System$146
- SYMPLICITY G3$144
- CARDIOMEMS$143
- Indigo System$142
- ENDOCROSS Device$136
- Torus Stent Graft System$136
- TandemLife$132
- AVVIGO Guidance System$131
- Endurant$131
- FLOWTRIEVER CATHETER, S$129
How this compares
$24,276 in reported general payments places this provider in the 80th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 55 | $73,163 |
| EntrestoSacubitril/Valsartan | 53 | $52,294 |
| XareltoRivaroxaban | 34 | $33,490 |
| JardianceEmpagliflozin | 26 | $30,507 |
| FarxigaDapagliflozin Propanediol | 35 | $23,907 |
| Repatha SureclickEvolocumab | 29 | $20,859 |
| BrilintaTicagrelor | 12 | $8,632 |
| Ranolazine ErRanolazine | 50 | $6,008 |
| Metoprolol Succinate | 170 | $1,725 |
| Diltiazem 12hr ErDiltiazem Hcl | 11 | $1,074 |
| ClopidogrelClopidogrel Bisulfate | 139 | $810 |
| Atorvastatin Calcium | 67 | $766 |
| Bisoprolol Fumarate | 28 | $758 |
| Losartan Potassium | 85 | $691 |
| Carvedilol | 119 | $641 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $684 | $73,16355 claims |
| NovartisEntresto | $974 | $52,29453 claims |
| Johnson & JohnsonXarelto | $143 | $33,49034 claims |
| AstraZenecaFarxiga, Brilinta | $195 | $32,53847 claims |
| Boehringer IngelheimJardiance | $19 | $30,50726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 129 interventional cardiology providers in Kentucky.
Other interventional cardiology in Lexington
- Avichai EresLexington$616K
- Steve LinLexington$362K
- Robert SawyerLexington$249K
- Ganesh Keshav ThirunavukkarasuLexington$220K
- Armaghan SoomroLexington$117K
- Adrian MesserliLexington$41K
- Henry Charles RichmondLexington$20K
- Michael ShihLexington$20K
- Mubashir QaziLexington$18K
- Michael RukavinaLexington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.